US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

696.04

+7.041.02%

Number of Gainers:78

Number of Losers:63

Number of Flat:13

PE:- -

High:698.21

Open:689.82

Low:685.07

Close:688.92

Volume:79.61M

Turnover:3.15B

Market Cap:481.21B

Float Cap:366.44B

Loading ...

Press Release: Inhibitor Therapeutics Highlights Key Developments and Reminds Stockholders of September 15 Annual Meeting

Cricut CEO Ashish Arora Disposes of 60,000 Common Shares Worth $336,330

iPower Announces Special Shareholder Meeting

Atai Beckley Holds Shareholder Meeting, Quorum Met with 65.6% Shares Represented

Keros Therapeutics Announces Share Repurchase Authorization Program

Sangamo Therapeutics Completes Key Technology Asset Sale

Robinhood initiated with a Buy at StoneX

Kanzhun Details September 2026 Option Exercises and Share Count Changes

Acurx Pharmaceuticals - Files for Resale of 1,500,000 Common Shares - SEC Filing

THOMSON REUTERS

Riskified Director Shachar Erez Disposes of USD 336,010 Common Shares

Xponential Fitness Appoints Jennifer Ryu as CFO Effective Oct. 19, 2026

Keros Therapeutics announces $5M share repurchase program after Takeda payment

Oklo initiated with an Overweight at Piper Sandler

Xponential Fitness, - Appoints Jennifer Ryu as CFO Effective October 19, 2026

THOMSON REUTERS

Xponential Fitness, - Robert Julian to Step Down as Interim CFO, Remain as Consultant

THOMSON REUTERS

Xponential Fitness, Inc. Appoints Jennifer Ryu as Chief Financial Officer

THOMSON REUTERS

Protara Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026

Press Release: Korsana Biosciences Completes Closing of Merger with Cyclerion Therapeutics and Previously Announced Private Placement of $380 Million

ME Therapeutics Advances Dual-Target CAR and STING mRNA Programs as NASDAQ Plans Progress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/BK4539/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":695.9597,"timestamp":1789139929407,"preClose":688.91504,"halted":0,"volume":79597745,"delay":0,"changeRate":0.010226,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":7.044678,"latestTime":"09-11 11:18:49 EDT","open":689.8237,"high":698.2087,"low":685.0665,"amount":3149854999.45096,"amplitude":0.019077,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789156800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.322493,"peRate":139.789284,"turnoverRate":0.00627,"increases":78,"decrements":64,"flats":8,"marketCap":481210228572.5,"floatMarketCap":366443410160.125},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":698.2087,"amplitude":0.019077,"preClose":688.91504,"low":685.0665,"pbRate":"5.322493","latestPrice":696.043,"volume":79613974,"delay":0,"open":689.8237,"prevYearClose":881.5255,"prevWeekClose":725.2816,"prevMonthClose":701.0681,"prevQuarterClose":742.922,"fiveDayClose":733.4782,"twentyDayClose":682.8836,"sixtyDayClose":729.1859,"secType":"PLATE","market":"US","turnoverRate":0.006272,"peRate":139.789284,"marketCap":481196950463,"floatMarketCap":366432070777.625,"timestamp":1789139934487,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":78,"down":63,"flat":13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666370726","title":"Press Release: Inhibitor Therapeutics Highlights Key Developments and Reminds Stockholders of September 15 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370726","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370726?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:59","pubTimestamp":1788904740,"startTime":"0","endTime":"0","summary":"TAMPA, Fla., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Inhibitor Therapeutics, Inc. (OTCQB: INTI) (\"Inhibitor\" or the \"Company\") today highlighted several important developments disclosed in its Quarterly Re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4585","LABU","BK4022","BK4139","R","INTI","BK4007","BK4232","BK4588","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370171","title":"Cricut CEO Ashish Arora Disposes of 60,000 Common Shares Worth $336,330","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370171","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370171?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:24","pubTimestamp":1788902647,"startTime":"0","endTime":"0","summary":"Cricut CEO Ashish Arora disposes of 60,000 common shares worth $336,330Cricut CEO Ashish Arora sold 60,000 Class A common shares on Sept. 4, 2026.Shares sold at a weighted average price of 5.61.Post-s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL3xWwlK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cricut CEO Ashish Arora Disposes of 60,000 Common Shares Worth $336,330","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRCT","BK4539","BK4191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370965","title":"iPower Announces Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370965","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370965?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:17","pubTimestamp":1788902252,"startTime":"0","endTime":"0","summary":"iPower announces special shareholder meetingiPower schedules a virtual special stockholder meeting on Sept. 21, 2026.Vote on authorizing up to USD 10 million in common stock issuance, capped at 10,000","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLbglcjB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4122","BK4539","IPW","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370615","title":"Atai Beckley Holds Shareholder Meeting, Quorum Met with 65.6% Shares Represented","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370615","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370615?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:10","pubTimestamp":1788901814,"startTime":"0","endTime":"0","summary":"Atai Beckley holds shareholder meeting, quorum met with 65.6% shares representedAtai Beckley held a virtual special shareholder meeting on Sept. 8, 2026 to vote on a merger agreement with Eli Lilly.Sh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL1JLSHz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014880.SGD","LU2896262040.SGD","FTXH","LLYX","LU0456855351.SGD","IE0001KFT4U8.USD","LU1712237335.SGD","LU0234572021.USD","BK4585","LLII","LU1145028129.USD","LU1548497426.USD","LU2112291526.USD","RXL","SGXZ99366536.SGD","LU0683600562.USD","ELIS","LU2602419157.SGD","WDNA","LU0094547139.USD","LU0320765992.SGD","LU2168564149.EUR","IE00B4JS1V06.HKD","SGXZ51526630.SGD","SG9999015952.SGD","LU2361044865.SGD","LU1623119135.USD","LU2237443978.SGD","TRUH","CURE","LU0133085943.USD","LU0238689110.USD","IE0004445015.USD","TMED","LU2168564065.EUR","LU2361044949.HKD","SGXZ31699556.SGD","LU1267930730.SGD","ELIL","LU0823434740.USD","LU2462157665.USD","LU1720051108.HKD","LU2023250504.SGD","LU1979441026.SGD","LU1868837136.USD","BK4533","FHLC","IE0004445239.USD","LU0198837287.USD","LU2471134523.USD","LU2491049909.HKD","LU2360106947.USD","SG9999014898.SGD","SG9999015945.SGD","SG9999018857.SGD","LU1983299246.USD","LU2237438978.USD","GB00BDT5M118.USD","LU0256863811.USD","LU1323610961.USD","SG9999015986.USD","IE00BKDWB100.SGD","LU2106854487.HKD","LU0061475181.USD","IE0009355771.USD","BK4516","LU0786609619.USD","LU2237443465.HKD","LU2271345857.HKD","LU0820562030.AUD","LU0158827781.USD","IE00BKPKM429.USD","LU0820561909.HKD","LU1691799644.USD","LU2461242641.AUD","LU0006306889.USD","SGXZ57979304.SGD","CANC","IE00B2B36J28.USD","LU0672654240.SGD","BK4599","LU2471134796.USD","SG9999013999.USD","LU0689472784.USD","LU0708995401.HKD","IE00BJLML261.HKD","LU2168563687.JPY","LU1232071149.USD","LU2361045086.USD","IE00B775H168.HKD","LU1868836757.USD","LU0122379950.USD","LU0058720904.USD","LU1064131342.USD","LU2746668461.USD","PPH","IE00B1BXHZ80.USD","LU0096364046.USD","LU2491050154.USD","IE00BK4W5M84.HKD","LU2108987350.USD","LU2168564222.USD","LU2746668974.SGD","VHT","LU1551013342.USD","LU0106261372.USD","SG9999001176.USD","IYH","LU0174119429.USD","LU0466842654.USD","BK4007","LU2552382215.SGD","SGXZ81514606.USD","IE00BK4W5L77.USD","LU0345770308.USD","LU1974910355.USD","LU2265009873.SGD","LU2211815571.USD","GDOC","IE00BFSS7M15.SGD","LU0943347566.SGD","LU1061106388.HKD","LU1989771016.USD","LU1291159041.SGD","LU0097036916.USD","LU0385154629.USD","LU2237443382.USD","LU2471134952.CNY","LU1280957306.USD","AGNG","IE00BWXC8680.SGD","LU0210536198.USD","LU2417539215.USD","LU0823416689.USD","SG9999015978.USD","IE0002141913.USD","LU0114720955.EUR","LU0289739699.SGD","LU0323591593.USD","LU0109394709.USD","LU2028103732.USD","BK4534","LU0079474960.USD","IXJ","LU1023059063.AUD","LU1093756325.SGD","LU0417517546.SGD","LU1629891620.HKD","LU2089283258.USD","PJP","LU1093756168.USD","LU2552382058.USD","SG9999014906.USD","LU2264538146.SGD","LU1720051017.SGD","SG9999018865.SGD","IHE","LU0203202063.USD","SG9999017495.SGD","LU0354030438.USD","LU0471298694.HKD","XLV","ATAI","LU1551013425.SGD","LU2087625088.SGD","LU2750360997.AUD","BK4581","LU2236285917.USD","IE00BJT1NW94.SGD","HRTS","LU0882574139.USD","SG9999014914.USD","MEDX","LU1917777945.USD","MEDI","LU0471298777.SGD","LU0320765059.SGD","LU2023250330.USD","IE00B4R5TH58.HKD","JDOC","IE00BFSS8Q28.SGD","THNR","LU0353189680.USD","LU1868837300.USD","LU2237443549.SGD","IE00BJJMRY28.SGD","LU0820561818.USD","SG9999001176.SGD","LU2491050071.SGD","IE00B7KXQ091.USD","LU2237443622.USD","IE00BJJMRX11.SGD","LU2357305700.SGD","LU2750360641.GBP","LU0823434583.USD","LU0353189763.USD","LU1868836591.USD","LLY","LU1069344957.HKD","LU2089284900.SGD","LU2023251221.USD","ILDR","LU0787776722.HKD","LU2462591350.SGD","MHIP","IE00BN29S564.USD","LU0316494557.USD","LU0432979614.USD","LU1868836914.USD","LU2237443895.HKD","LU0256863902.USD","LU0203201768.USD","LU2468319806.SGD","LU2552382132.HKD","LU0354030511.USD","LU2756315664.SGD","LU2324357040.USD","LU1035775433.USD","OZEM","LU1366192091.USD","LU0345770993.USD","LU0964807845.USD","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU0109391861.USD","LU1127390331.HKD","LU1804176565.USD","LU1814569148.SGD","BK4539","LU0889565916.HKD","LU0158827948.USD","LLYZ","LU0266013472.USD","LU2063271972.USD","LU2089984988.USD","LU2471134879.HKD","IE00BFTCPJ56.SGD","LU2111349929.HKD","LU2756315318.SGD","IE00B1XK9C88.USD","LU2213496289.HKD","BK4588","LU2168564495.EUR","LU0225283273.USD","LU2456880835.USD","LU0640476718.USD","LU1988902786.USD","IE0005OL40V9.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666713377","title":"Keros Therapeutics Announces Share Repurchase Authorization Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666713377","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666713377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:38","pubTimestamp":1788899909,"startTime":"0","endTime":"0","summary":"Keros Therapeutics ( ($KROS) ) just unveiled an announcement. On September 8, 2026, Keros Therapeutics announced that its board had authorized a $5...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/keros-therapeutics-announces-share-repurchase-authorization-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/keros-therapeutics-announces-share-repurchase-authorization-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KROS","LENZ","BK4139","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377200","title":"Sangamo Therapeutics Completes Key Technology Asset Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377200","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377200?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:32","pubTimestamp":1788899575,"startTime":"0","endTime":"0","summary":"Sangamo Therapeutics ( ($SGMOQ) ) has issued an announcement. On September 4, 2026, Sangamo Therapeutics completed the court-approved sale of subst...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sangamo-therapeutics-completes-key-technology-asset-sale?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sangamo-therapeutics-completes-key-technology-asset-sale?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666784377","title":"Robinhood initiated with a Buy at StoneX","url":"https://stock-news.laohu8.com/highlight/detail?id=2666784377","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666784377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:30","pubTimestamp":1788899409,"startTime":"0","endTime":"0","summary":"StoneX analyst Mark Palmer initiated coverage of Robinhood (HOOD) with a Buy rating and $170 price target Published first on TheFly – the ultimate ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/robinhood-initiated-with-a-buy-at-stonex-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/robinhood-initiated-with-a-buy-at-stonex-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLCK","CRPT","BK4539","HOOI","LU0566484027.USD","LU0053671581.USD","LU1861559042.SGD","HOII","ROBN","HOOC","HOOY","HOYY","FINX","LU1559883803.SGD","HOOX","HOOD","LU1861558580.USD","IAI","LU1815336091.USD","BK4547","BK4127","HOOG","HOOZ","HODU","SNEX","LU0757428866.USD","HOOW","BPAY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377793","title":"Kanzhun Details September 2026 Option Exercises and Share Count Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377793","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377793?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:28","pubTimestamp":1788899314,"startTime":"0","endTime":"0","summary":"Kanzhun Ltd Sponsored ( ($BZ) ) has issued an announcement. Kanzhun Limited filed a Form 6-K with the U.S. Securities and Exchange Commission on Se...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kanzhun-details-september-2026-option-exercises-and-share-count-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kanzhun-details-september-2026-option-exercises-and-share-count-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0359201612.USD","BK4509","BZ","LU2929501877.USD","BK4551","BK4588","BK4505","BK4526","LU1023057109.AUD","BK4130","BK4585","IE00B29SXG58.USD","BK4535","LU2351347302.SGD","BK4503","LU2039709279.SGD","BK4077","BK4539","LU1688375341.USD","BK4563","LU0359202008.SGD","LU2187417386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377609","title":"Acurx Pharmaceuticals - Files for Resale of 1,500,000 Common Shares - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377609","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377609?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:28","pubTimestamp":1788899307,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN4500VQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","BK4563","ACXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666369377","title":"Riskified Director Shachar Erez Disposes of USD 336,010 Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666369377","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666369377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:13","pubTimestamp":1788898419,"startTime":"0","endTime":"0","summary":"Riskified director Shachar Erez disposes of USD 336,010 common sharesRiskified director Shachar Erez reported selling 50,000 Class A Ordinary Shares on Sept. 3, 2026.Sale priced at USD 6.72 per share.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL9v9FBT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Riskified Director Shachar Erez Disposes of USD 336,010 Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","RSKD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666337204","title":"Xponential Fitness Appoints Jennifer Ryu as CFO Effective Oct. 19, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666337204","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666337204?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:06","pubTimestamp":1788897978,"startTime":"0","endTime":"0","summary":"Xponential Fitness appoints Jennifer Ryu as CFO effective Oct. 19, 2026Xponential Fitness named Jennifer Ryu chief financial officer, effective Oct. 19, 2026.Ryu previously served as executive vice pr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLhGvvG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4216","LU1878469433.USD","XPOF","BK4539","RGP","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377658","title":"Keros Therapeutics announces $5M share repurchase program after Takeda payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377658","media":"TIPRANKS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377658?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897915,"startTime":"0","endTime":"0","summary":"Keros Therapeutics (KROS) announced that its board of directors has approved a $5M share repurchase program of the company’s common stock following...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/keros-therapeutics-announces-5m-share-repurchase-program-after-takeda-payment-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/keros-therapeutics-announces-5m-share-repurchase-program-after-takeda-payment-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","KROS","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377570","title":"Oklo initiated with an Overweight at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377570","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377570?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897907,"startTime":"0","endTime":"0","summary":"Piper Sandler initiated coverage of Oklo (OKLO) with an Overweight rating and $55 price target Published first on TheFly – the ultimate source for ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oklo-initiated-with-an-overweight-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oklo-initiated-with-an-overweight-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4606","URAN","URA","OKLC","NLR","OKLO","OKLL","BK4081","OKLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372740","title":"Xponential Fitness, - Appoints Jennifer Ryu as CFO Effective October 19, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372740","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372740?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897901,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA1YN0Y5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4216","BK4539","XPOF","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372726","title":"Xponential Fitness, - Robert Julian to Step Down as Interim CFO, Remain as Consultant","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372726","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372726?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897901,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA1YN0Y5:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1878469433.USD","BK4216","XPOF","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666037271","title":"Xponential Fitness, Inc. Appoints Jennifer Ryu as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2666037271","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666037271?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897901,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA1YN0Y5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","XPOF","LU1878469433.USD","BK4216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666937739","title":"Protara Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666937739","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666937739?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897900,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept.  08, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc.(Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, toda","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3358109/0/en/protara-therapeutics-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666396377","title":"CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666396377","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666396377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897900,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., Sept.  08, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-target","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3358105/0/en/camp4-therapeutics-to-host-virtual-analyst-day-to-discuss-cmp-002-for-the-treatment-of-syngap1-related-disorder-on-september-28-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASO","BK4539","BK4139","CMP","LENZ","BK4561","BK4168","BK4200","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372093","title":"Press Release: Korsana Biosciences Completes Closing of Merger with Cyclerion Therapeutics and Previously Announced Private Placement of $380 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372093","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372093?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897900,"startTime":"0","endTime":"0","summary":"Advancing lead program KRSA-028 toward the clinic, with Phase 1 healthy volunteer data expected mid-2027 and interim proof-of-concept data in Alzheimer's patients anticipated by year-end 2027 or first","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","03160","BK4555","BK4539","BK4588","BK4585","BK4139","BK4099","BK4604","TM","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372117","title":"ME Therapeutics Advances Dual-Target CAR and STING mRNA Programs as NASDAQ Plans Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372117","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372117?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:32","pubTimestamp":1788895960,"startTime":"0","endTime":"0","summary":"An announcement from ME Therapeutics Holdings, Inc. ( ($TSE:METX) ) is now available. ME Therapeutics reported progress in its in vivo CD19/CD22-ta...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/me-therapeutics-advances-dual-target-car-and-sting-mrna-programs-as-nasdaq-plans-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/me-therapeutics-advances-dual-target-car-and-sting-mrna-programs-as-nasdaq-plans-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QQQA","QID",".IXIC","PSQ","QQQ","LENZ","QDTE","BK4139","QQQJ","TQQQ","JEPQ","GPIQ","BK4097","03086","NVIW.SI","QLD","ONEQ","QQQM","SQQQ","QQQY","NDX","TQQY","LU2065732104.USD","BK4539","BK4007","QQQE","PRGS","QYLG","FTEC","IYW","NQmain","MNQmain","TECS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":45,"pageCount":13,"totalSize":896,"code":"91000000","status":"200"}]}}